Abstracts deadline Friday 24 April 2026! Submit now

d
h
m
s

Abstracts deadline EXTENDED Friday 22 May 2026! Submit now

d
h
m
s
Days
Hrs
Mins

Prof Soo-Kyung Cho

From September 2011 to August 2012 Dr Cho was a research associate in the Department of Pharmacovigilance at Tokyo Medical and Dental University Japan Upon returning to Korea in 2012 she was appointed Assistant Professor in the Department of Internal Medicine at Hanyang University Later from September 2018 to August 2019 she furthered her expertise in pharmacoepidemiology and pharmacoeconomics as a visiting professor at the Division of Pharmacoepidemiology and Pharmacoeconomics Brigham and Womens Hospital Harvard Medical School USACurrently Dr Cho is a professor and clinician in the Department of Rheumatology and the Section of Pharmacoepidemiology at HUHRDDr Chos research interests in rheumatology are broad with a focus on clinical epidemiologic studies utilizing diseasespecific cohorts and national claims databases Since 2011 her work has centered on evaluating the effectiveness and safety of biologic agents and antirheumatic drugs contributing significantly to the advancement of knowledge and care in rheumatic diseases

From September 2011 to August 2012 Dr Cho was a research associate in the Department of Pharmacovigilance at Tokyo Medical and Dental University Japan Upon returning to Korea in 2012 she was appointed Assistant Professor in the Department of Internal Medicine at Hanyang University Later from September 2018 to August 2019 she furthered her expertise in pharmacoepidemiology and pharmacoeconomics as a visiting professor at the Division of Pharmacoepidemiology and Pharmacoeconomics Brigham and Womens Hospital Harvard Medical School USACurrently Dr Cho is a professor and clinician in the Department of Rheumatology and the Section of Pharmacoepidemiology at HUHRDDr Chos research interests in rheumatology are broad with a focus on clinical epidemiologic studies utilizing diseasespecific cohorts and national claims databases Since 2011 her work has centered on evaluating the effectiveness and safety of biologic agents and antirheumatic drugs contributing significantly to the advancement of knowledge and care in rheumatic diseases

Sessions

Presentations

Share

Key dates

Registrations
Abstracts

More speakers

Prof Soumya Raychaudhuri
Harvard Medical School, Brigham and Women's Hospital, United States
A/Prof Paulo Lorenzo
President, APLAR. Philippines
Prof Gulen Hatemi
Istanbul University - Cerrahpasa. Turkiye
Prof. Xenofon Baraliakos
Rheumazentrum Ruhrgebiet, Europe
Dr. Anindita Santosa
Aaria Rheumatology, Singapore
Prof. Mandana Nikpour
The University of Sydney, Australia
Days
Hours
Minutes
Seconds
Until 11:59PM AEST Tuesday 23 June, 2026

The countdown is on

Have you registered yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.

Days
Hours
Minutes
Seconds
Until 11:59PM AEST Friday 24 April, 2026

The countdown is on

Have you submitted your abstract yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.